Medical Strategy and Launch Excellence

Focus Area Working Group

The strategic mission and objectives of the Medical Affairs Professional Society (MAPS) Medical Strategy and Launch Excellence Focus Area Working Group are to create a community that advances our role as fully integrated strategic business partners for internal stakeholders; to develop our medical strategy and launch excellence community within MAPS to become the premier global destination of choice for MA Professionals responsible for leading medical strategy; and to catalyze our individual personal leadership development and professional career advancement.

Activities: 

We will organize medical strategy and launch excellence workshops for MAPS meetings in North America, APAC (Asia Pacific – China/Japan), and EMEA (Europe, Middle East, Asia) regions. We develop original content for webinars, podcasts, eLearning courses and white papers. In addition, the working group will periodically contribute cogent and timely content for the MAPS online publication, Elevate. Most importantly, we will serve as a supportive resource for all Medical Affairs Professionals.

Strategic Objectives

#1 Enable Medical Affairs leadership in strategic Launch Excellence planning and execution:

Define core competencies needed across MA functions to achieve Medical Launch Excellence
Define and share best practices that embody the delivery of exceptional value in Medical Launch Excellence

#2 Ensure the highest level of Medical Affairs asset and organizational strategic planning capabilities:

Enhance strategic MA organizational planning to maximize capabilities and future investment
Standardize the approach to MA Asset Strategic Planning, integrating external perspectives and collaborating with cross-functional partners
Ensure MA Asset Strategic Planning incorporates global, regional, and local needs

Latest Podcast Episode

Description:

Understand how the medical affairs strategic planning process can drive decision making throughout the year. Gain insight into the value medical affairs bring across an organization when an effective, collaborative, aligned medical strategy plan is developed

Members

Rebecca (Becky) Harmon

COO, Diabetes Drug Development

Co-Lead

Simon Kyaga

Global Medical Director, Alzheimer’s Disease, for Europe Canada and Partner Markets (ECP)

Co-Lead

Safura Babu-Kahn

Senior Director & Transversal Medical Strategy Lead

Chet Bhatt

Executive Director, Global Medical Operations and Strategic Programs

Cesar Cerezo

Chief Medical Officer

Sarah Clark

Global Head of Medical Affairs and Operations, Biogen Digital Health

Vandana Garg

Medical Innovation Director

Emily Howman

Medical Strategy Lead

David Kelaher

Chief Medical Officer

Charlotte Mosley

Executive Director – Client Engagement

Arron Mungul

Director Global Medical Capabilities

Jennifer Pappadakis

VP, Global Medical External Affairs

Marija Simin Geertsen

Vice-President, Medical Affairs

Paul Tebbey

Vice-President, Medical Affairs Biosimilars

Leah Williams

Director, Medical Education & Communications

Troels Wolther

Executive Medical Director

FAWG Overview

View FAWG Charter

Resources Related to Medical Strategy and Launch Excellence

This paper discusses the sources and uses of non-registrational evidence and describes why Medical Affairs is positioned to lead and own the nRE Strategic Plan.

non registrational evidence medical affairs

This paper discusses the sources and uses of non-registrational evidence and describes why Medical Affairs is positioned to lead and own the nRE Strategic Plan.

MAPS speaks with leaders from Lundbeck, Biogen, BMS and Medline about new best practices for the product launch planning process.

This white paper from the MAPS Medical Strategy & Launch Excellence Focus Area Working Group (FAWG) describes the elements of meaningful metrics in Medical Affairs and demonstrates how these metrics can be used to facilitate real actions and outcomes for Medical Affairs teams and the organization as a whole

This webinar will feature speakers from Eli Lilly and Company, Gilead, and Pfizer. They will come together to represent their experiences in establishing medical information strategy, content and operations for Emergency Use Authorization (EUA) products for the prevention and treatment of COVID-19.

Building a Next Generation Community of Medical Affairs with Mentorship

Three accomplished Medical Affairs executives representing different regions of the globe have helped build the inaugural Mentorship Program at MAPS will be discussing their personal stories, perspectives, and offer critical suggestions that will redefine and inspire a next generation view of Mentorship

This MAPS Webinar details SWOT Analysis and teaches participants to recognize how to apply the outputs of a SWOT analysis to strategic business planning efforts.

Navigating Stakeholder Ecosystems: Diversity of Insights in Medical Affairs

Historically, Medical Affairs strategy focused heavily on engaging with KOLs. Today’s Medical Affairs team engages with a much more diverse ecosystem of stakholders

Companies are investing more in the analytics and insights capabilities for medical – whether it’s dedicating more resources, building out a center of excellence, or even having Commercial Ops and Analytics people transition to take on that role in Medical.

View all FAWGs

All Focus Area Working Groups

Connect with Us

Policies